Cargando…
New concept of the glucagon‐like peptide‐1 signaling pathway on pancreatic insulin secretion
The intracellular glucagon‐like peptide‐1 (GLP‐1) signaling pathway, which involves cyclic adenosine monophosphate (cAMP), exchange protein directly activated by cAMP, cAMP‐dependent protein kinase A (PKA) and adenosine triphosphate‐sensitive potassium channels, has been widely accepted as a common...
Autor principal: | Kaku, Kohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078078/ https://www.ncbi.nlm.nih.gov/pubmed/31472102 http://dx.doi.org/10.1111/jdi.13136 |
Ejemplares similares
-
Are both protein kinase A‐ and protein kinase C‐dependent pathways involved in glucagon‐like peptide‐1 action on pancreatic insulin secretion?
por: Shigeto, Makoto, et al.
Publicado: (2014) -
Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion
por: Kimura, Tomohiko, et al.
Publicado: (2022) -
Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells
por: Caporarello, Nunzia, et al.
Publicado: (2017) -
Glucagon-Like Peptide-1 and Diabetes
por: Monami, Matteo
Publicado: (2011) -
Glucagon-Like Peptide-1 and Diabetes 2012
por: Monami, Matteo, et al.
Publicado: (2012)